These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 9109871

  • 1. Quantification of brain metabolites in amyotrophic lateral sclerosis by localized proton magnetic resonance spectroscopy.
    Gredal O, Rosenbaum S, Topp S, Karlsborg M, Strange P, Werdelin L.
    Neurology; 1997 Apr; 48(4):878-81. PubMed ID: 9109871
    [Abstract] [Full Text] [Related]

  • 2. Proton magnetic resonance spectroscopy of the motor cortex in 70 patients with amyotrophic lateral sclerosis.
    Pohl C, Block W, Karitzky J, Träber F, Schmidt S, Grothe C, Lamerichs R, Schild H, Klockgether T.
    Arch Neurol; 2001 May; 58(5):729-35. PubMed ID: 11346367
    [Abstract] [Full Text] [Related]

  • 3. Reduced NAA in motor and non-motor brain regions in amyotrophic lateral sclerosis: a cross-sectional and longitudinal study.
    Rule RR, Suhy J, Schuff N, Gelinas DF, Miller RG, Weiner MW.
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Sep; 5(3):141-9. PubMed ID: 15512902
    [Abstract] [Full Text] [Related]

  • 4. Decreased N-acetylaspartate in motor cortex and corticospinal tract in ALS.
    Rooney WD, Miller RG, Gelinas D, Schuff N, Maudsley AA, Weiner MW.
    Neurology; 1998 Jun; 50(6):1800-5. PubMed ID: 9633731
    [Abstract] [Full Text] [Related]

  • 5. A proton magnetic resonance spectroscopic study in ALS: correlation with clinical findings.
    Ellis CM, Simmons A, Andrews C, Dawson JM, Williams SC, Leigh PN.
    Neurology; 1998 Oct; 51(4):1104-9. PubMed ID: 9781537
    [Abstract] [Full Text] [Related]

  • 6. Effect of creatine supplementation on metabolite levels in ALS motor cortices.
    Vielhaber S, Kaufmann J, Kanowski M, Sailer M, Feistner H, Tempelmann C, Elger CE, Heinze HJ, Kunz WS.
    Exp Neurol; 2001 Dec; 172(2):377-82. PubMed ID: 11716561
    [Abstract] [Full Text] [Related]

  • 7. The ratio of N-acetyl aspartate to glutamate correlates with disease duration of amyotrophic lateral sclerosis.
    Sako W, Abe T, Izumi Y, Harada M, Kaji R.
    J Clin Neurosci; 2016 May; 27():110-3. PubMed ID: 26765768
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Proton MR spectroscopy studies of the brain in ALS patients].
    Bak MI, Domzał-Stryga A, Królicki L, Kwieciński H.
    Neurol Neurochir Pol; 2001 May; 35(1 Suppl):61-70. PubMed ID: 11732281
    [Abstract] [Full Text] [Related]

  • 10. Proton magnetic resonance spectroscopy of the primary motor cortex in patients with motor neuron disease: subgroup analysis and follow-up measurements.
    Block W, Karitzky J, Träber F, Pohl C, Keller E, Mundegar RR, Lamerichs R, Rink H, Ries F, Schild HH, Jerusalem F.
    Arch Neurol; 1998 Jul; 55(7):931-6. PubMed ID: 9678310
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Comprehensive evaluation of corticospinal tract metabolites in amyotrophic lateral sclerosis using whole-brain 1H MR spectroscopy.
    Govind V, Sharma KR, Maudsley AA, Arheart KL, Saigal G, Sheriff S.
    PLoS One; 2012 Jul; 7(4):e35607. PubMed ID: 22539984
    [Abstract] [Full Text] [Related]

  • 13. Brain metabolites in definite amyotrophic lateral sclerosis. A longitudinal proton magnetic resonance spectroscopy study.
    Unrath A, Ludolph AC, Kassubek J.
    J Neurol; 2007 Aug; 254(8):1099-106. PubMed ID: 17431700
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Motor neuron diseases: comparison of single-voxel proton MR spectroscopy of the motor cortex with MR imaging of the brain.
    Chan S, Shungu DC, Douglas-Akinwande A, Lange DJ, Rowland LP.
    Radiology; 1999 Sep; 212(3):763-9. PubMed ID: 10478245
    [Abstract] [Full Text] [Related]

  • 16. Quantification of brain metabolites in ALS by localized proton magnetic spectroscopy.
    Ikeda K, Iwasaki Y, Kinoshita M, Ichijo M, Fujii H, Matsuoka Y, Irimajiri S.
    Neurology; 1998 Feb; 50(2):576-7. PubMed ID: 9484413
    [No Abstract] [Full Text] [Related]

  • 17. Magnetic resonance imaging and 1H-magnetic resonance spectroscopy in amyotrophic lateral sclerosis.
    Sarchielli P, Pelliccioli GP, Tarducci R, Chiarini P, Presciutti O, Gobbi G, Gallai V.
    Neuroradiology; 2001 Mar; 43(3):189-97. PubMed ID: 11305749
    [Abstract] [Full Text] [Related]

  • 18. Diffusion tensor MRI and MR spectroscopy in long lasting upper motor neuron involvement in amyotrophic lateral sclerosis.
    Lombardo F, Frijia F, Bongioanni P, Canapicchi R, Minichilli F, Bianchi F, Hlavata H, Rossi B, Montanaro D.
    Arch Ital Biol; 2009 Sep; 147(3):69-82. PubMed ID: 20014653
    [Abstract] [Full Text] [Related]

  • 19. Decrease in N-acetylaspartate/creatine ratio in the motor area and the frontal lobe in amyotrophic lateral sclerosis.
    Abe K, Takanashi M, Watanabe Y, Tanaka H, Fujita N, Hirabuki N, Yanagihara T.
    Neuroradiology; 2001 Jul; 43(7):537-41. PubMed ID: 11512581
    [Abstract] [Full Text] [Related]

  • 20. 1H-magnetic resonance spectroscopy in amyotrophic lateral sclerosis.
    Bradley WG, Bowen BC, Pattany PM, Rotta F.
    J Neurol Sci; 1999 Oct 31; 169(1-2):84-6. PubMed ID: 10540013
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.